{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:31:36Z","timestamp":1793309496595,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:00:00Z","timestamp":1789257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0410015"],"award-info":[{"award-number":["JP18fk0410015"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fk0410015"],"award-info":[{"award-number":["JP19fk0410015"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0410015"],"award-info":[{"award-number":["JP20fk0410015"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007951","name":"Tokyo Medical and Dental University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154580","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:41:21Z","timestamp":1789141281000},"page":"154580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of novel diimide and hydrazone scaffolds for synergistic HIV-1 shock and kill strategies"],"prefix":"10.1016","volume":"836","author":[{"given":"Sayaka","family":"Sukegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9864-6646","authenticated-orcid":false,"given":"Haruki","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0826-2940","authenticated-orcid":false,"given":"Kousuke","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-2413","authenticated-orcid":false,"given":"Chieko","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-2608","authenticated-orcid":false,"given":"Takuya","family":"Kobayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Tsukitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Tamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5689-9858","authenticated-orcid":false,"given":"Hiroaki","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154580_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.880030","article-title":"Application of CRISPR\/Cas genomic editing tools for HIV therapy: toward precise modifications and multilevel protection","volume":"12","author":"Maslennikova","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154580_bib2","article-title":"Current status of HIV-1 vaccines","volume":"9","author":"Hargrave","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bbrc.2026.154580_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101211","article-title":"Broadly neutralizing antibodies against HIV-1 and concepts for application","volume":"54","author":"Gruell","year":"2022","journal-title":"Curr. Opin. Virol."},{"issue":"7408","key":"10.1016\/j.bbrc.2026.154580_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154580_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1021\/acs.jnatprod.0c01039","article-title":"Discovering the mechanisms of wikstroelide E as a potential HIV-Latency-Reversing agent by transcriptome profiling","volume":"84","author":"Li","year":"2021","journal-title":"J. Nat. Prod."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154580_bib6","first-page":"11739","article-title":"XQ2, a novel derivative of resveratrol, reactivates latent HIV-1 via the activation of positive transcription elongation factor B","volume":"11","author":"Lai","year":"2026","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154580_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/v16111783","article-title":"NSC95397 is a novel HIV-1 latency-reversing agent","volume":"16","author":"Nichols Doyle","year":"2024","journal-title":"Viruses"},{"issue":"5\u20136","key":"10.1016\/j.bbrc.2026.154580_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2119\/molmed.2011.00076","article-title":"Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir","volume":"17","author":"Matalon","year":"2011","journal-title":"Mol Med"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154580_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4161\/cc.23309","article-title":"BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism","volume":"12","author":"Boehm","year":"2013","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154580_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/138945011794815266","article-title":"Activation of latent HIV-1 expression by protein kinase C agonists. A novel therapeutic approach to eradicate HIV-1 reservoirs","volume":"12","author":"S\u00e1nchez-Duffhues","year":"2011","journal-title":"Curr. Drug Targets"},{"issue":"9","key":"10.1016\/j.bbrc.2026.154580_bib11","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.celrep.2019.10.101","article-title":"Latency-reversing agents induce differential responses in distinct memory CD4 T cell subsets in individuals on antiretroviral therapy","volume":"29","author":"Pardons","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154580_bib12","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154580_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005063","article-title":"An In-Depth comparison of latency-reversing agent combinations in various in vitro and Ex vivo HIV-1 latency models identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to potently reactivate viral gene expression","volume":"11","author":"Darcis","year":"2015","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154580_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15252\/emmm.201505557","article-title":"Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1","volume":"8","author":"Bouchat","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154580_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QAI.0000000000001958","article-title":"Heterogeneous HIV-1 reactivation patterns of disulfiram and combined disulfiram+Romidepsin treatments","volume":"80","author":"Kula","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154580_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16816-1","article-title":"BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154580_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005066","article-title":"Synergistic reactivation of latent HIV expression by Ingenol-3-Angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation","volume":"11","author":"Jiang","year":"2015","journal-title":"PLoS Pathog."},{"issue":"10227","key":"10.1016\/j.bbrc.2026.154580_bib18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0140-6736(19)32990-3","article-title":"Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial","volume":"395","author":"Fidler","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bbrc.2026.154580_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005142","article-title":"The depsipeptide romidepsin reverses HIV-1 latency in vivo","volume":"11","author":"Sogaard","year":"2015","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154580_bib20","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","article-title":"Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial","volume":"1","author":"Rasmussen","year":"2014","journal-title":"Lancet HIV"},{"issue":"12","key":"10.1016\/j.bbrc.2026.154580_bib21","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1016\/S2352-3018(15)00226-X","article-title":"Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study","volume":"2","author":"Elliott","year":"2015","journal-title":"Lancet HIV"},{"issue":"7408","key":"10.1016\/j.bbrc.2026.154580_bib22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154580_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007991","article-title":"Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations","volume":"15","author":"Grau-Exp\u00f3sito","year":"2019","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154580_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007619","article-title":"Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection","volume":"15","author":"Pardons","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2026.154580_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/srep24157","article-title":"Monocyte-derived macrophages exhibit distinct and more restricted HIV-1 integration site repertoire than CD4(+) T cells","volume":"6","author":"Kok","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154580_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.chom.2016.07.015","article-title":"Single-cell characterization of viral translation-competent reservoirs in HIV-infected individuals","volume":"20","author":"Baxter","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.bbrc.2026.154580_bib27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm.4319","article-title":"HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy","volume":"23","author":"Honeycutt","year":"2017","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154580_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41564-018-0335-z","article-title":"HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy","volume":"4","author":"Ganor","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bbrc.2026.154580_bib29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3389\/fimmu.2019.01435","article-title":"The HIV reservoir in monocytes and macrophages","volume":"10","author":"Wong","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154580_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48681-5","article-title":"HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirus","volume":"9","author":"Iwase","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154580_bib31","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1038\/s41598-018-21942-5","article-title":"BI-2536 and BI-6727, dual Polo-like kinase\/bromodomain inhibitors, effectively reactivate latent HIV-1","volume":"8","author":"Gohda","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154580_bib32","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2026.154580_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbrc.2022.12.024","article-title":"4-phenylquinoline-8-amine induces HIV-1 reactivation and apoptosis in latently HIV-1 infected cells","volume":"641","author":"Kitamura","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154580_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2021.06.017","article-title":"Identification and characterization of stathmin 1 as a host factor involved in HIV-1 latency","volume":"567","author":"Deletsu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154580_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymeth.2010.04.005","article-title":"Isolation and functional characterization of P-TEFb-associated factors that control general and HIV-1 transcriptional elongation","volume":"53","author":"Chen","year":"2011","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154580_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154580_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1006\/abbi.1993.1311","article-title":"Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction","volume":"303","author":"Berridge","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154580_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1074\/jbc.RA118.005798","article-title":"Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversal","volume":"294","author":"Matsuda","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154580_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2026.154580_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154580_bib41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"W1","key":"10.1016\/j.bbrc.2026.154580_bib42","doi-asserted-by":"crossref","first-page":"W212","DOI":"10.1093\/nar\/gkz446","article-title":"Ma'ayan A: ChEA3: transcription factor enrichment analysis by orthogonal omics integration","volume":"47","author":"Keenan","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154580_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molcel.2006.06.014","article-title":"Controlling the elongation phase of transcription with P-TEFb","volume":"23","author":"Peterlin","year":"2006","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154580_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01361-18","article-title":"Synthetic ingenols maximize protein kinase C-Induced HIV-1 latency reversal","volume":"62","author":"Spivak","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"40","key":"10.1016\/j.bbrc.2026.154580_bib45","doi-asserted-by":"crossref","first-page":"42008","DOI":"10.1074\/jbc.M402124200","article-title":"Prostratin antagonizes HIV latency by activating NF-kappaB","volume":"279","author":"Williams","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154580_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(96)00785-5","article-title":"Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes","volume":"392","author":"Gschwendt","year":"1996","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154580_bib47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.15252\/emmm.201708193","article-title":"Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency","volume":"10","author":"Hashemi","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154580_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.20411\/pai.v2i2.204","article-title":"HIV infection of macrophages: implications for pathogenesis and cure","volume":"2","author":"Clayton","year":"2017","journal-title":"Pathog Immun"},{"key":"10.1016\/j.bbrc.2026.154580_bib49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-4939-7493-1_17","article-title":"Methods for high-throughput drug combination screening and synergy scoring","volume":"1711","author":"He","year":"2018","journal-title":"Methods Mol. Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601346X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2601346X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:52:03Z","timestamp":1793307123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2601346X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0006291X2601346X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154580","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel diimide and hydrazone scaffolds for synergistic HIV-1 shock and kill strategies","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154580"}}